#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ependymoma Cerebellar ataxia Liposarcoma Fallopian tube cancer PIK3CA related overgrowth spectrum Arteriovenous malformation Vascular malformation Still's disease Raynaud's phenomenon Stargardt's disease Congenital hypotransferrinaemia Hyperphagia Prolymphocytic leukaemia Graft versus host disease Tuberous sclerosis complex More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Life with Disease Biotinidase deficiency – Basic Information MELAS syndrome – Life with Disease Idiopathic pulmonary fibrosis – Diagnostics Hyperoxaluria – Treatment Netherton’s syndrome – Basic Information Acute respiratory distress syndrome – Treatment Progressive multifocal leukoencephalopathy Acquired haemophilia – Trials in Disease Vascular malformation – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALLERGEN EXTRACTS Dexamethasone Sodium Phosphate Safinamide Gskvx000000014593 Adezunap Human Mesenchymal Stem Cells Pp1815 Naloxone Hydrochloride Voriconazole Opevesostat A3907 Chlorhexidine Gluconate Interferon Beta-1B Methotrexate Sodium Atropine Sulfate Monohydrate Cl-Ad-Msc-002 Gemcitabine Hydrochloride Pirfenidone Piperacillin Sodium Cefotaxime More therapies…

    Learn about Your Condition

    Menopause Peripheral artery thrombosis Acute cardiac event Demyelination Septic shock Arteriovenous graft thrombosis CDKL5 deficiency disorder Vomiting Leukocyte adhesion deficiency Diabetic foot infection Oedema peripheral Angiosarcoma non-metastatic Pigmentary glaucoma Stomatitis Choreoathetosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Memantine Hydrochloride for Adolescents with Bipolar Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Memantine Hydrochloride
    Italy

  • Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Nitrogen
    • Nitrous Oxide
    • Oxygen
    France

  • Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Lumateperone
    Bulgaria Romania

  • Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

    Not recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Germany Greece +3

  • Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Lumateperone
    Bulgaria Croatia

  • Study on Psilocybin, Ketamine, and Midazolam for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Psilocybine
    • Ketamine Hydrochloride
    • Midazolam
    Czechia
Previous Page
1 … 33 34 35 36 37 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!